Back to today’s briefing

Story perspectives

Ekso Bionics Shifts Focus, Promises Revenue Surge Ahead

6/7/2025

50 4

Summary

Story summary

Ekso Bionics Holdings Inc. is revolutionizing mobility with its cutting-edge exoskeleton technology. Although the company faced a net loss of $0.12 per share in Q1 2025, it is pivoting towards personal-use devices like the Ekso Indego Personal. Analysts foresee a surge in revenue, solidifying Ekso's status as a frontrunner in wearable robotics.

1 of 1

Story summary

Ekso Bionics Holdings Inc. is revolutionizing mobility with its cutting-edge exoskeleton technology. Although the company faced a net loss of $0.12 per share in Q1 2025, it is pivoting towards personal-use devices like the Ekso Indego Personal. Analysts foresee a surge in revenue, solidifying Ekso's status as a frontrunner in wearable robotics.